The push-pull debate between the U.S. Senate and various stakeholders in the pharmaceutical industry continues at a heated pace. Yet, while policymakers and pharma executives initially agreed on the prospective benefits of removing rebates for certain stakeholders,...
You don’t have to lose money because of expired products. You’ve got a partner who can change that, right here, right now. In any business, especially pharmacies, unproductive stock is money that counts – but gathering, returning, and tracking these expired products...
